ACE2 News and Research

RSS
Nafamostat mesylate initially reduces SARS-CoV-2 viral loads in hamsters, study finds

Nafamostat mesylate initially reduces SARS-CoV-2 viral loads in hamsters, study finds

Endothelial cells resistant to SARS-CoV-2 infection

Endothelial cells resistant to SARS-CoV-2 infection

Identifying SARS-CoV-2 spike protein mutations resistant to antibodies

Identifying SARS-CoV-2 spike protein mutations resistant to antibodies

ACE2 and TMPRSS2 not the only virus-receptors to mediate SARS-CoV-2 entry

ACE2 and TMPRSS2 not the only virus-receptors to mediate SARS-CoV-2 entry

Immune-evading variants can emerge in SARS-CoV-2, researchers warn

Immune-evading variants can emerge in SARS-CoV-2, researchers warn

Study shows SARS-CoV-2 direct heart muscle cell infection, cell death, loss of contractility

Study shows SARS-CoV-2 direct heart muscle cell infection, cell death, loss of contractility

SARS-CoV-2 viral antigens found in non-pulmonary tissues in recovering patients

SARS-CoV-2 viral antigens found in non-pulmonary tissues in recovering patients

Innate immunity key to limiting viral load in COVID-19 cases

Innate immunity key to limiting viral load in COVID-19 cases

Universal nanoparticle platform may help in rapid development of a COVID-19 vaccine

Universal nanoparticle platform may help in rapid development of a COVID-19 vaccine

Reducing the airborne transmission risk for SARS-CoV-2

Reducing the airborne transmission risk for SARS-CoV-2

Researchers identify antibodies that prevent SARS-CoV-2 from infecting human cells

Researchers identify antibodies that prevent SARS-CoV-2 from infecting human cells

Green tea and some fruit juices inhibit SARS-CoV-2 in vitro

Green tea and some fruit juices inhibit SARS-CoV-2 in vitro

Computational study reveals SARS-CoV-2 spike protein structural stability

Computational study reveals SARS-CoV-2 spike protein structural stability

An analysis of genetic diversity of D614G mutation in SARS-CoV-2

An analysis of genetic diversity of D614G mutation in SARS-CoV-2

D614G mutation enhances stability of SARS-CoV-2 spike protein

D614G mutation enhances stability of SARS-CoV-2 spike protein

Study shows brilacidin strongly inhibits SARS-CoV-2 in laboratory cell lines

Study shows brilacidin strongly inhibits SARS-CoV-2 in laboratory cell lines

Synthetic antibody may prevent coronavirus from infecting human cells

Synthetic antibody may prevent coronavirus from infecting human cells

Evidence of robust and persistent antibodies against SARS-CoV-2

Evidence of robust and persistent antibodies against SARS-CoV-2

Rapid generation of divergent synthetic antibodies against SARS-CoV-2 in a cell-free engineering platform

Rapid generation of divergent synthetic antibodies against SARS-CoV-2 in a cell-free engineering platform

Beta-blockers could be used to treat COVID-19, study finds

Beta-blockers could be used to treat COVID-19, study finds